Research Square

Depressive symptoms linked to later chronic lung disease

Across three cohorts, adults with depressive symptoms had about 50% higher relative risk of developing chronic lung disease than those without symptoms.

Paper by Tian Gao, Xuewei Zhao, Bixiang Liu, 6 more authorsAiming Zheng · The Fourth Affiliated Hospital of Nanjing Medical University
Figure 1. Flow diagram of participant selection for the primary, symptom subtype, and trajectory analyses in CHARLS, HRS, and SHARE.
Open the figure at full size
Figure 1. Flow diagram of participant selection for the primary, symptom subtype, and trajectory analyses in CHARLS, HRS, and SHARE.Flow diagram of participant selection for the primary, symptom subtype, and trajectory analyses in CHARLS, HRS, and SHARE.Gao et al.
Preprint: cohort study of 117,160 adults without baseline chronic lung disease, 6 to 10 yearsPopulations

Multicenter

Limit: Chronic lung disease diagnoses relied on participant reports

Edited by Boris Djordjevic · AgingResearch.News

Follow

A pooled analysis of three prospective observational cohorts included 117,160 adults in China, the United States and Europe who initially had neither chronic lung disease nor asthma. Researchers recorded 9,275 new cases of chronic lung disease. The association with depressive symptoms remained after accounting for smoking, age and other measured factors.

Physical symptoms of depression and symptoms involving mood and thinking were each independently linked to later lung disease. The link was slightly stronger for physical symptoms. In a separate analysis of 57,241 participants, persistently high symptoms over the first three survey rounds were associated with the greatest risk during later follow-up. People whose symptoms decreased still had elevated risk, though the association was weaker.

Why it matters

Depression has often been viewed as a consequence of chronic lung disease. Examining whether depressive symptoms precede it may inform research on maintaining lung health with age.

Caveats

The observational design cannot establish cause and effect, and the analysis excluded people who already had chronic lung disease or asthma. This preprint has not been peer-reviewed, and depression scales and cutoffs differed across cohorts.

From the paper

Participants

The primary analytic sample comprised 117,160 participants (CHARLS n = 12,775; HRS n = 29,845; SHARE n = 74,540).

Methods, Study design and population

Result

In CHARLS (n = 12,670; 1,756 events), per one standard deviation (SD) increase, the somatic subscale was associated with an HR of 1.18 (95% CI 1.11-1.25; P < 0.001) and the cognitive-affective subscale with an HR of 1.13 (95% CI 1.07-1.20; P < 0.001).

Results, Symptom subtype analysis

Limitation

Residual confounding cannot be excluded, although E-values (2.4–2.5) indicated that a relatively strong unmeasured confounder would be needed to explain away the association.

Strengths and limitations

Quoted word for word from the full text on researchsquare.com.

Comments

Be the first to comment.